
SOPH Stock Forecast & Price Target
SOPH Analyst Ratings
Bulls say
Sophia Genetics is a well-positioned company with a strong presence in the healthcare technology sector. Its partnerships and success in analyzing complex data sets make it a desirable company for investors. With expansion into the US market and strong financial metrics, Sophia Genetics is poised for continued growth and success.
Bears say
Sophia Genetics is a healthcare technology company that is struggling to achieve profitability due to high sales and marketing costs and seasonal fluctuations in revenue. The company's platform, which converts raw health data into actionable insights, has potential, but is currently underpenetrated in the US market. Additionally, the company faces competition and risks related to commercial expansion, cybersecurity, and legal and IP. Even with new applications and a favorable contract with Microsoft, the company's financials show losses and it is uncertain if and when they will reach profitability.
This aggregate rating is based on analysts' research of Sophia Genetics SA and is not a guaranteed prediction by Public.com or investment advice.
SOPH Analyst Forecast & Price Prediction
Start investing in SOPH
Order type
Buy in
Order amount
Est. shares
0 shares